Table 3.
Antibiotic Parameters Tested |
Rate of Susceptibility (%) |
p-Value | Antibiotic Parameters Tested |
Rate of Susceptibility (%) |
p-Value |
---|---|---|---|---|---|
Amikacin | Tetracycline | ||||
Humans | 96.8 | 0.114 | Humans | 93.5 | 0.234 |
Hares | 100 | Hares | 99.0 | ||
Voles | 100 | Voles | 97.4 | ||
Palencia | 100 | --- (ns) | Palencia | 98.3 | 0.767 |
Valladolid | 100 | Valladolid | 96.1 | ||
Zamora | 100 | Zamora | 97.2 | ||
1997–1998 | 100 | < 0.01 * | 1997–1998 | 90.0 | 0.009 * |
1999–2006 | 75 | 1999–2006 | 100 | ||
2007–2010 | 100 | 2007–2010 | 100 | ||
2014–2015 | 100 | 2014–2015 | 100 | ||
2016–2017 | 100 | 2016–2017 | 86.7 | ||
2019–2020 | 100 | 2019–2020 | 100 | ||
Gentamicin | Ciprofloxacin | ||||
Humans | 100 | 0.594 | Humans | 100 | 0.594 |
Hares | 99.0 | Hares | 99.0 | ||
Voles | 97.4 | Voles | 97.4 | ||
Palencia | 98.3 | 0.482 | Palencia | 98.3 | 0.713 |
Valladolid | 100 | Valladolid | 98.0 | ||
Zamora | 100 | Zamora | 100 | ||
1997–1998 | 100 | 0.679 | 1997–1998 | 100 | 0.392 |
1999–2006 | 100 | 1999–2006 | 100 | ||
2007–2010 | 97.1 | 2007–2010 | 98.6 | ||
2014–2015 | 100 | 2014–2015 | 100 | ||
2016–2017 | 100 | 2016–2017 | 93.3 | ||
2019–2020 | 100 | 2019–2020 | 100 | ||
Tobramycin | |||||
Humans | 100 | 0.446 | |||
Hares | 96.9 | ||||
Voles | 94.7 | ||||
Palencia | 96.7 | 0.329 | |||
Valladolid | 94.1 | ||||
Zamora | 100 | ||||
1997–1998 | 100 | 0.712 | |||
1999–2006 | 100 | ||||
2007–2010 | 95.7 | ||||
2014–2015 | 97.4 | ||||
2016–2017 | 93.3 | ||||
2019–2020 | 100 |
Ns, not significant; * Significant p-values are highlighted in red.